One study showed that the absence of IL-33 was more common in MCI patients who converted to AD at 1-year follow-up visits than in those who did not convert to AD; overall, the cognitive function in patients expressing IL-33 was better preserved than in patients who did not express it [118]. Here, IL33 is linked to Alzheimer disease.